Arca
Skip to content
Tools
Tools

Allergies environmental

Drug research and approvals for allergies environmental: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 18 studies of allergies environmental are recruiting on ClinicalTrials.gov, and Health Canada has authorized 14 drug trials for it since 2013.

  • Recruiting worldwide: 18
  • Trials authorized in Canada: 14
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 18 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

The 10 newest of 14; search them all in Canada trials
Jun 18, 2015"a randomized, double-blind, placebo-controlled, multi-center study of the efficacy and safety of STG320 sublingual tablets of house dust mite (HDM) allergen…STG320 hdm sublingual tabletsStallergenes S.A.Ongoing
May 28, 2015"the impact of grass slit treatment on birch pollen induced allergic rhinitis - a pilot evaluation. "Grastek (standardized timothy grass pollen)Kingston General HospitalOngoing
Apr 17, 2015"a dose-response evaluation of the sq tree slit-tablet in subjects with moderate to severe allergic rhinoconjunctivitis induced by pollens from the birch group…Sq tree slit-tabletALK-AbellóClosed
Apr 8, 2015An observational follow-on field study to evaluate the continued efficacy and safety of ragweed-spire treatment in ragweed allergic subjects approximately one…Ragweed-spireCircassia PharmaceuticalsClosed
Oct 15, 2014A phase IV, open-label, safety and tolerability trial of MK-3641 and MK-7243 co-administered in subjects at least 18 years of age with ragweed and grass pollen…Grastek, RagwitekMerck & Co. (MSD)Ongoing
Sep 11, 2014A double-blind, randomized, placebo-controlled, multi-centre field study to assess the efficacy and safety of hdm-spire in subjects with a history of house…Hdm-spire (toleromune house dust mite)Circassia PharmaceuticalsOngoing
Aug 21, 2014A double-blind, placebo-controlled, randomized trial to compare the efficacy and tolerability of three dose regimens of allert, a combination of contiguous…AllertAnergis S.A.Ongoing
Aug 8, 2014Double-blind, placebo-controlled randomized trial to study the viaskin milk efficacy and safety for treating ige-mediated cow's milk allergy in childrenViaskin milk (DBV135)DBV TechnologiesClosed
Mar 28, 2014A multi-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the safety and tolerability of grass-spire in subjects with asthma…Grass-spire (toleromune grass)Circassia PharmaceuticalsOngoing
Jan 29, 2014A single center, randomized, double-masked, placebo-controlled, parallel group study to assess the efficacy and safety of EBI-005 topical ophthalmic solution…EBI-005Eleven BiotherapeuticsOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.